Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular TargetsCorrado Pelaia, Giorgio Walter Canonica, Girolamo Pelaia et al.|Frontiers in Pharmacology|2022Cited by 157
Tezepelumab: A Potential New Biological Therapy for Severe Refractory AsthmaCorrado Pelaia, Alessandro Vatrella, Giulia Pelaia et al.|International Journal of Molecular Sciences|2021Cited by 74